These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 18762181

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
    Palmer JA, Higuera ES, Chang L, Chaplan SR.
    Neuroscience; 2008 Jul 17; 154(4):1554-61. PubMed ID: 18541380
    [Abstract] [Full Text] [Related]

  • 23. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 17; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 24. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA, Khasabov S, Paz J, Harding-Rose C, Simone DA, Seybold VS.
    J Neurosci; 2012 May 16; 32(20):7091-101. PubMed ID: 22593077
    [Abstract] [Full Text] [Related]

  • 25. N-arachidonylethanolamide-induced increase in aqueous humor outflow facility.
    Njie YF, Qiao Z, Xiao Z, Wang W, Song ZH.
    Invest Ophthalmol Vis Sci; 2008 Oct 16; 49(10):4528-34. PubMed ID: 18539938
    [Abstract] [Full Text] [Related]

  • 26. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.
    Solinas M, Justinova Z, Goldberg SR, Tanda G.
    J Neurochem; 2006 Jul 16; 98(2):408-19. PubMed ID: 16805835
    [Abstract] [Full Text] [Related]

  • 27. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
    Schlosburg JE, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Apr 16; 329(1):314-23. PubMed ID: 19168707
    [Abstract] [Full Text] [Related]

  • 28. The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats.
    Altun A, Ozdemir E, Yildirim K, Gursoy S, Durmus N, Bagcivan I.
    Gen Physiol Biophys; 2015 Oct 16; 34(4):433-40. PubMed ID: 26374993
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H, Drew GM, Christie MJ, Vaughan CW.
    Br J Pharmacol; 2011 Jul 16; 163(6):1214-22. PubMed ID: 21175570
    [Abstract] [Full Text] [Related]

  • 35. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.
    Reis GM, Ramos MA, Pacheco Dda F, Klein A, Perez AC, Duarte ID.
    Life Sci; 2011 Apr 11; 88(15-16):653-7. PubMed ID: 21277864
    [Abstract] [Full Text] [Related]

  • 36. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM, Guindon J, Hohmann AG.
    Pharmacol Res; 2010 Sep 11; 62(3):249-58. PubMed ID: 20416378
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C, Markert A, Zimmer A.
    Eur Neuropsychopharmacol; 2015 Aug 11; 25(8):1388-96. PubMed ID: 25910421
    [Abstract] [Full Text] [Related]

  • 38. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 11; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 39. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul 11; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan 11; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.